Uterine Conditions Easy to Miss During the Menopausal Transition
Women in their 40s and 50s experience a range of physical changes as they approach menopause. Their menstrual cycles may become irregular, or the...
Search results for "cancer treatment"
Lung Cancer Five-Year Survival Reaches 71% for High-Income Patients but Only 37% for Low-Income Group
While advancements in lung cancer treatment have steadily boosted overall survival rates in South Korea, a substantial gap persists based on...
Asan Medical Center Introduces Korea’s First Transperineal Robotic Prostate Biopsy System
In prostate cancer diagnostics, minimizing procedural infection risks is as vital as accurately sampling suspicious...
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the...
Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment
Hanmi Pharmaceutical has unveiled a next-generation cancer technology designed to deliver drugs to the tumor...
Beyond Facial Wrinkles: 5 Internal Factors Accelerating Biological Aging
Aging is an inevitable biological process, but the rate at which it occurs is largely within individual control.
Spatial Mapping of Residual Esophageal Cancer Reveals Genetic Clues to Recurrence Risk
Researchers have identified key genetic markers that could help estimate the risk of recurrence in esophageal cancer...
Found a Breast Lump? Why Immediate Mammotome Removal Isn't Always the First Step
While lying on the ultrasound examination table, hearing the doctor say, "I see a lump here," instantly triggers...
Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters
Lung cancer is the second most commonly diagnosed cancer in South Korea and the leading cause of cancer mortality,...
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...